NDC 71288-413 – Eptifibatide
Eptifibatide .75 mg/mL · Injection, Solution · Intravenous
Product NDC71288-413
Product details
- Brand name
- Eptifibatide
- Generic name
- Eptifibatide
- Labeler
- Meitheal Pharmaceuticals Inc.
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213599
- Marketed since
- May 9, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Platelet Aggregation Inhibitor
Active ingredients
- Eptifibatide .75 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 71288-413-51 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-413-51) / 100 mL in 1 VIAL, SINGLE-DOSE | May 9, 2024 |
Other Eptifibatide products
- 83634-301 Eptifibatide .75 mg/mL · Injection, Solution · Avenacy, LLC
- 83634-300 Eptifibatide 2 mg/mL · Injection, Solution · Avenacy, LLC
- 0338-9558 Eptifibatide 75 mg/100mL · Injection · Baxter Healthcare Company
- 55150-218 Eptifibatide 75 mg/100mL · Injection · Eugia US LLC
- 55150-219 Eptifibatide 20 mg/10mL · Injection · Eugia US LLC
- 55150-220 Eptifibatide 200 mg/100mL · Injection · Eugia US LLC
- 52958-040 Eptifibatide .75 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 52958-402 Eptifibatide 2 mg/mL · Injection, Solution · Hainan Shuangcheng Pharmaceuticals Co., Ltd.
- 71288-412 Eptifibatide 2 mg/mL · Injection, Solution · Meitheal Pharmaceuticals Inc.
- 67457-629 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 67457-630 Eptifibatide 2 mg/mL · Injection, Solution · Mylan Institutional LLC
- 67457-631 Eptifibatide .75 mg/mL · Injection, Solution · Mylan Institutional LLC